Transaction · 0001193125-26-363567

LEONARD JOHN M

LEONARD JOHN M, PRES, reported an open-market or private sale at Intellia Therapeutics, Inc. involving 19890.000000 shares for an estimated $250614.00. Reported holdings after the transaction were 1149849.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES
NTLAIntellia Therapeutics, Inc.
Filing timeAug 24
Trade dateAug 20, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$12.56
Pre-filing
1mo ago -8.7%1w ago -5.8%1d ago +5.7%
Returns since
7d +8.3%30d +8.3%90d +8.3%180d +8.3%1y +8.3%

NTLA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NTLA since 2026-08-24Filed 11 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-363567
Common Stock
Transaction date
Aug 20, 2026
Filed Aug 24, 2026, 08:05 PM · 4d delay
Shares
19.8k sh
$1.26k per share
Estimated value
-$25.0M
Computed from shares × price
Holdings after
1.14M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.32 to $13.00, inclusive. Upon request by the Commission staff, th…

  3. F3

    Shares held by the John M. Leonard 2015 Irrevocable Trust.

Original filing · 0001193125-26-363567
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NTLA